UBS Group reissued their neutral rating on shares of Victrex (LON:VCT) in a research report report published on Thursday, ThisIsMoney.Co.Uk reports. The firm currently has a GBX 2,150 ($28.09) target price on the stock, down from their previous target price of GBX 2,225 ($29.07).
Other equities analysts have also issued research reports about the stock. JPMorgan Chase & Co. increased their target price on shares of from GBX 2,300 ($30.05) to GBX 2,900 ($37.89) and gave the company a neutral rating in a research report on Friday, July 5th. Barclays reiterated an underweight rating and issued a GBX 1,900 ($24.83) target price on shares of in a research report on Friday, June 28th. Liberum Capital reiterated a buy rating and issued a GBX 74 ($0.97) target price on shares of Speedy Hire in a research report on Wednesday, May 15th. Peel Hunt reiterated a buy rating on shares of John Menzies in a research report on Friday, July 5th. Finally, Numis Securities reiterated a buy rating on shares of BT Group – CLASS A in a research report on Monday, May 13th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. The stock has a consensus rating of Hold and an average target price of GBX 2,308.64 ($30.17).
Shares of VCT opened at GBX 2,022 ($26.42) on Thursday. The firm has a 50-day moving average of GBX 2,078.24. The company has a market cap of $1.75 billion and a price-to-earnings ratio of 17.58. Victrex has a 52-week low of GBX 1,943 ($25.39) and a 52-week high of GBX 3,434 ($44.87).
In other news, insider Timothy (Tim) J. Cooper bought 710 shares of the firm’s stock in a transaction on Monday, May 20th. The stock was bought at an average cost of GBX 1,266 ($16.54) per share, for a total transaction of £8,988.60 ($11,745.20). Also, insider Jane Toogood bought 500 shares of the firm’s stock in a transaction on Friday, May 31st. The stock was purchased at an average price of GBX 1,972 ($25.77) per share, with a total value of £9,860 ($12,883.84). In the last 90 days, insiders have bought 4,227 shares of company stock valued at $8,198,142.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
Featured Article: What is a Tariff?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.